MapLight Therapeutics, Inc. MPLT EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by MapLight Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The official record: MapLight Therapeutics, Inc. ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about MapLight Therapeutics, Inc. 's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is MapLight Therapeutics, Inc. 's EPS (diluted)?
- MapLight Therapeutics, Inc. (MPLT) reported EPS (diluted) of -$1.34 in Q1 2026.
- How has MapLight Therapeutics, Inc. 's EPS (diluted) changed year-over-year?
- MapLight Therapeutics, Inc. 's EPS (diluted) increased by 95.4% year-over-year, from -$29.33 to -$1.34.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.